<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38710760</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>06</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection.</ArticleTitle><Pagination><StartPage>10388</StartPage><MedlinePgn>10388</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10388</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-57448-6</ELocationID><Abstract><AbstractText>Research into the molecular basis of disease trajectory and Long-COVID is important to get insights toward underlying pathophysiological processes. The objective of this study was to investigate inflammation-mediated changes of metabolism in patients with acute COVID-19 infection and throughout a one-year follow up period. The study enrolled 34 patients with moderate to severe COVID-19 infection admitted to the University Clinic of Innsbruck in early 2020. The dynamics of multiple laboratory parameters (including inflammatory markers [C-reactive protein (CRP), interleukin-6 (IL-6), neopterin] as well as amino acids [tryptophan (Trp), phenylalanine (Phe) and tyrosine (Tyr)], and parameters of iron and vitamin B metabolism) was related to disease severity and patients' physical performance. Also, symptom load during acute illness and at approximately 60&#xa0;days (FU1), and one year after symptom onset (FU2) were monitored and related with changes of the investigated laboratory parameters: During acute infection many investigated laboratory parameters were elevated (e.g., inflammatory markers, ferritin, kynurenine, phenylalanine) and enhanced tryptophan catabolism and phenylalanine accumulation were found. At FU2 nearly all laboratory markers had declined back to reference ranges. However, kynurenine/tryptophan ratio (Kyn/Trp) and the phenylalanine/tyrosine ratio (Phe/Tyr) were still exceeding the 95th percentile of healthy controls in about two thirds of our cohort at FU2. Lower tryptophan concentrations were associated with B vitamin availability (during acute infection and at FU1), patients with lower vitamin B12 levels at FU1 had a prolonged and more severe impairment of their physical functioning ability. Patients who had fully recovered (ECOG 0) presented with higher concentrations of iron parameters (ferritin, hepcidin, transferrin) and amino acids (phenylalanine, tyrosine) at FU2 compared to patients with restricted ability to work. Persistent symptoms at FU2 were tendentially associated with IFN-&#x3b3; related parameters. Women were affected by long-term symptoms more frequently. Conclusively, inflammation-mediated biochemical changes appear to be related to symptoms of patients with acute and Long Covid.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gietl</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkert</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofer</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innrain 80, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gostner</LastName><ForeName>Johanna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innrain 80, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnweber</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tancevski</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pizzini</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahanic</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroll</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brigo</LastName><ForeName>Natascha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egger</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Central Institute for Medical and Chemical Laboratory Diagnostics (ZIMCL), Tirol Kliniken GmbH, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellmann-Weiler</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;ffler-Ragg</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. Guenter.Weiss@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. katharina.kurz@i-med.ac.at.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant><Grant><GrantID>GZ 75759</GrantID><Agency>TYROLEAN REGIONAL GOVERNMENT</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>8DUH1N11BX</RegistryNumber><NameOfSubstance UI="D014364">Tryptophan</NameOfSubstance></Chemical><Chemical><RegistryNumber>670-65-5</RegistryNumber><NameOfSubstance UI="D019798">Neopterin</NameOfSubstance></Chemical><Chemical><RegistryNumber>47E5O17Y3R</RegistryNumber><NameOfSubstance UI="D010649">Phenylalanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076604" MajorTopicYN="N">Physical Functional Performance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014364" MajorTopicYN="N">Tryptophan</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019798" MajorTopicYN="N">Neopterin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010649" MajorTopicYN="N">Phenylalanine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>7</Day><Hour>0</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>7</Day><Hour>0</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>6</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38710760</ArticleId><ArticleId IdType="pmc">PMC11074335</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-57448-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-57448-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26(4):450&#x2013;452. doi: 10.1038/s41591-020-0820-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0820-9</ArticleId><ArticleId IdType="pmc">PMC7095063</ArticleId><ArticleId IdType="pubmed">32284615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu RJ, Yu WC, Peng GR, et al. The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections. Front. Immunol. 2022;13:832394. doi: 10.3389/fimmu.2022.832394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.832394</ArticleId><ArticleId IdType="pmc">PMC9021400</ArticleId><ArticleId IdType="pubmed">35464491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93(1):250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G. Coronavirus disease 2019: Clinics, treatment, and prevention. Front. Microbiol. 2021;12:761887. doi: 10.3389/fmicb.2021.761887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.761887</ArticleId><ArticleId IdType="pmc">PMC8631905</ArticleId><ArticleId IdType="pubmed">34858373</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004;136(1):95&#x2013;103. doi: 10.1111/j.1365-2249.2004.02415.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02415.x</ArticleId><ArticleId IdType="pmc">PMC1808997</ArticleId><ArticleId IdType="pubmed">15030519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;04(104):8&#x2013;13. doi: 10.1016/j.cyto.2018.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC7129230</ArticleId><ArticleId IdType="pubmed">29414327</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int. J. Infect. Dis. 2020;96:467&#x2013;474. doi: 10.1016/j.ijid.2020.05.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.055</ArticleId><ArticleId IdType="pmc">PMC7233226</ArticleId><ArticleId IdType="pubmed">32425643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji P, Zhu J, Zhong Z, et al. Association of elevated inflammatory markers and severe COVID-19: A meta-analysis. Medicine (Baltimore) 2020;99(47):e23315. doi: 10.1097/MD.0000000000023315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000023315</ArticleId><ArticleId IdType="pmc">PMC7676531</ArticleId><ArticleId IdType="pubmed">33217868</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J. Clin. Med. 2020 doi: 10.3390/jcm9082429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082429</ArticleId><ArticleId IdType="pmc">PMC7464087</ArticleId><ArticleId IdType="pubmed">32751400</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;cksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta. 2006;364(1&#x2013;2):82&#x2013;90. doi: 10.1016/j.cca.2005.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2005.06.013</ArticleId><ArticleId IdType="pubmed">16139256</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroecksnadel K, Sarcletti M, Winkler C, et al. Quality of life and immune activation in patients with HIV-infection. Brain Behav. Immun. 2008;22(6):881&#x2013;889. doi: 10.1016/j.bbi.2007.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.12.011</ArticleId><ArticleId IdType="pubmed">18261883</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroecksnadel K, Zangerle R, Bellmann-Weiler R, Garimorth K, Weiss G, Fuchs D. Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. Curr. Drug Metab. 2007;8(3):225&#x2013;236. doi: 10.2174/138920007780362608.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920007780362608</ArticleId><ArticleId IdType="pubmed">17430111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L, Kink P, Egger EM, et al. Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer. Front. Immunol. 2020;11:249. doi: 10.3389/fimmu.2020.00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00249</ArticleId><ArticleId IdType="pmc">PMC7047328</ArticleId><ArticleId IdType="pubmed">32153576</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG. Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br. J. Cancer. 2002;86(11):1691&#x2013;1696. doi: 10.1038/sj.bjc.6600336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6600336</ArticleId><ArticleId IdType="pmc">PMC2375406</ArticleId><ArticleId IdType="pubmed">12087451</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R, Lanser L, Burkert F, et al. Neopterin predicts disease severity in hospitalized patients with COVID-19. Open Forum Infect. Dis. 2021;8(1):ofaa521. doi: 10.1093/ofid/ofaa521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa521</ArticleId><ArticleId IdType="pmc">PMC7665702</ArticleId><ArticleId IdType="pubmed">33442554</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect. Dis. 2020;20(1):942. doi: 10.1186/s12879-020-05671-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05671-7</ArticleId><ArticleId IdType="pmc">PMC7726600</ArticleId><ArticleId IdType="pubmed">33302893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozger HS, Dizbay M, Corbacioglu SK, et al. The prognostic role of neopterin in COVID-19 patients. J. Med. Virol. 2021;93(3):1520&#x2013;1525. doi: 10.1002/jmv.26472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26472</ArticleId><ArticleId IdType="pubmed">32860465</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Algon AAA, Al-Hakeim HK, Maes M. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2022;22(1):615. doi: 10.1186/s12879-022-07582-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Wright Muelas M, Taylor JM, et al. Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome. Metabolomics. 2023;19(11):87. doi: 10.1007/s11306-023-02048-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-023-02048-0</ArticleId><ArticleId IdType="pmc">PMC10584727</ArticleId><ArticleId IdType="pubmed">37853293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Ai G, Chen L, et al. Associations of immunological features with COVID-19 severity: A systematic review and meta-analysis. BMC Infect. Dis. 2021;21(1):738. doi: 10.1186/s12879-021-06457-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06457-1</ArticleId><ArticleId IdType="pmc">PMC8329624</ArticleId><ArticleId IdType="pubmed">34344353</ArticleId></ArticleIdList></Reference><Reference><Citation>Canli T, Lesch KP. Long story short: The serotonin transporter in emotion regulation and social cognition. Nat. Neurosci. 2007;10(9):1103&#x2013;1109. doi: 10.1038/nn1964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1964</ArticleId><ArticleId IdType="pubmed">17726476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tordjman S, Chokron S, Delorme R, et al. Melatonin: Pharmacology, functions and therapeutic benefits. Curr. Neuropharmacol. 2017;15(3):434&#x2013;443. doi: 10.2174/1570159X14666161228122115.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X14666161228122115</ArticleId><ArticleId IdType="pmc">PMC5405617</ArticleId><ArticleId IdType="pubmed">28503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773. doi: 10.1371/journal.pone.0063773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063773</ArticleId><ArticleId IdType="pmc">PMC3656905</ArticleId><ArticleId IdType="pubmed">23691095</ArticleId></ArticleIdList></Reference><Reference><Citation>Coon SL, Roseboom PH, Baler R, et al. Pineal serotonin N-acetyltransferase: Expression cloning and molecular analysis. Science. 1995;270(5242):1681&#x2013;1683. doi: 10.1126/science.270.5242.1681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.270.5242.1681</ArticleId><ArticleId IdType="pubmed">7502081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietl M, Burkert F, Seiwald S, et al. Interferon-gamma mediated metabolic pathways in hospitalized patients during acute and reconvalescent COVID-19. Int. J. Tryptophan. Res. 2023;16:11786469231154244. doi: 10.1177/11786469231154244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11786469231154244</ArticleId><ArticleId IdType="pmc">PMC10076985</ArticleId><ArticleId IdType="pubmed">37038445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;, Ero&#x11f;lu B, G&#xfc;ven GS. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) Nutrition. 2021;90:111308. doi: 10.1016/j.nut.2021.111308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2021.111308</ArticleId><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs D, Hausen A, Reibnegger G, et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur. J. Haematol. 1991;46(2):65&#x2013;70. doi: 10.1111/j.1600-0609.1991.tb00524.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0609.1991.tb00524.x</ArticleId><ArticleId IdType="pubmed">1899833</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs D, Jaeger M, Widner B, Wirleitner B, Artner-Dworzak E, Leblhuber F. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin. Chem. Lab. Med. 2001;39(8):691&#x2013;694. doi: 10.1515/CCLM.2001.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2001.113</ArticleId><ArticleId IdType="pubmed">11592434</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: A prospective observational cohort study. Respir. Res. 2020;21(1):276. doi: 10.1186/s12931-020-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudzki L, Stone TW, Maes M, Misiak B, Samochowiec J, Szulc A. Gut microbiota-derived vitamins - underrated powers of a multipotent ally in psychiatric health and disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;107:110240. doi: 10.1016/j.pnpbp.2020.110240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.110240</ArticleId><ArticleId IdType="pubmed">33428888</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40&#x2013;50. doi: 10.1182/blood-2018-06-856500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-06-856500</ArticleId><ArticleId IdType="pmc">PMC6536698</ArticleId><ArticleId IdType="pubmed">30401705</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista KS, Cintra VM, Lucena PAF, et al. The role of vitamin B12 in viral infections: A comprehensive review of its relationship with the muscle-gut-brain axis and implications for SARS-CoV-2 infection. Nutr. Rev. 2022;80(3):561&#x2013;578. doi: 10.1093/nutrit/nuab092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuab092</ArticleId><ArticleId IdType="pmc">PMC8689946</ArticleId><ArticleId IdType="pubmed">34791425</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzanares W, Hardy G. Vitamin B12: The forgotten micronutrient for critical care. Curr. Opin. Clin. Nutr. Metab. Care. 2010;13(6):662&#x2013;668. doi: 10.1097/MCO.0b013e32833dfaec.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0b013e32833dfaec</ArticleId><ArticleId IdType="pubmed">20717016</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeri H, Azimian A, Ghasemzadeh-Moghaddam H, et al. Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19. J. Med. Virol. 2022;94(1):141&#x2013;146. doi: 10.1002/jmv.27277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27277</ArticleId><ArticleId IdType="pmc">PMC8426973</ArticleId><ArticleId IdType="pubmed">34406674</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsayad OA, Abdou SM. Relation between vitamin B12 levels and smell affection in COVID-19 patients. Int. Arch. Otorhinolaryngol. 2022;26(4):e533&#x2013;e537. doi: 10.1055/s-0042-1755311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1755311</ArticleId><ArticleId IdType="pmc">PMC9668420</ArticleId><ArticleId IdType="pubmed">36405468</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassiano LMG, Cavalcante-Silva V, Oliveira MS, et al. Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19. Front. Immunol. 2023;14:1048790. doi: 10.3389/fimmu.2023.1048790.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1048790</ArticleId><ArticleId IdType="pmc">PMC10040807</ArticleId><ArticleId IdType="pubmed">36993968</ArticleId></ArticleIdList></Reference><Reference><Citation>Lymperaki E, Kazeli K, Variti G, et al. Potential role of certain biomarkers such as vitamin B12, ROS, albumin, as early predictors for prognosis of COVID-19 outcomes. Medicines (Basel) 2022 doi: 10.3390/medicines9060036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicines9060036</ArticleId><ArticleId IdType="pmc">PMC9229029</ArticleId><ArticleId IdType="pubmed">35736249</ArticleId></ArticleIdList></Reference><Reference><Citation>Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int. J. Infect. Dis. 2020;100:390&#x2013;393. doi: 10.1016/j.ijid.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.08.018</ArticleId><ArticleId IdType="pmc">PMC7418699</ArticleId><ArticleId IdType="pubmed">32795605</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Mayersbach P, Becker K, Schennach H, Fuchs D, Gostner JM. Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors. Pteridines. 2015;26:31&#x2013;36. doi: 10.1515/pterid-2014-0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/pterid-2014-0015</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs D, M&#xf6;ller AA, Reibnegger G, et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol. Lett. 1991;28(3):207&#x2013;211. doi: 10.1016/0165-2478(91)90005-u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-2478(91)90005-u</ArticleId><ArticleId IdType="pubmed">1909303</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurauter G, Schr&#xf6;cksnadel K, Scholl-B&#xfc;rgi S, et al. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr. Drug Metab. 2008;9(7):622&#x2013;627. doi: 10.2174/138920008785821738.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920008785821738</ArticleId><ArticleId IdType="pubmed">18781914</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur. Respir. J. 2020 doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L, Burkert FR, Bellmann-Weiler R, et al. Dynamics in Anemia development and dysregulation of iron homeostasis in hospitalized patients with COVID-19. Metabolites. 2021 doi: 10.3390/metabo11100653.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11100653</ArticleId><ArticleId IdType="pmc">PMC8540370</ArticleId><ArticleId IdType="pubmed">34677368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19(3):141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: When a chromosome makes the difference. Nat. Rev. Immunol. 2010;10(8):594&#x2013;604. doi: 10.1038/nri2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2815</ArticleId><ArticleId IdType="pubmed">20651746</ArticleId></ArticleIdList></Reference><Reference><Citation>Haitao T, Vermunt JV, Abeykoon J, et al. COVID-19 and sex differences: Mechanisms and biomarkers. Mayo Clin. Proc. 2020;95(10):2189&#x2013;2203. doi: 10.1016/j.mayocp.2020.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7402208</ArticleId><ArticleId IdType="pubmed">33012349</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2019 doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475&#x2013;481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin. Rev. Allergy Immunol. 2023;64(1):90&#x2013;107. doi: 10.1007/s12016-022-08921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-022-08921-5</ArticleId><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezgin Y. Evaluation of serum vitamin B12 levels in patients with COVID-19 infection: A case-control study. J. Med. Biochem. 2023;42(3):524&#x2013;529. doi: 10.5937/jomb0-42357.</Citation><ArticleIdList><ArticleId IdType="doi">10.5937/jomb0-42357</ArticleId><ArticleId IdType="pmc">PMC10543489</ArticleId><ArticleId IdType="pubmed">37790208</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>